Jci_page_head_homepage_01 Jci_page_head_homepage_02
Farah Sheikh, Anna Raskin, Pao-Hsien Chu, Stephan Lange, Andrea A. Domenighetti, Ming Zheng, Xingqun Liang, Tong Zhang, Toshitaka Yajima, Yusu Gu, Nancy D. Dalton, Sushil K. Mahata, Gerald W. Dorn, Joan Heller-Brown, Kirk L. Peterson, Jeffrey H. Omens, Andrew D. McCulloch, Ju Chen
Published in Volume 118, Issue 12
J Clin Invest. 2008; 118(12):3870–3880 doi:10.1172/JCI34472
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Jci0834472
Figure 5
Working model for the pathways that link defects in the MAPK/FHL1/titin complex to cardiac sarcomere extensibility and hypertrophic signaling.

Left: FHL1 is a component of the stretch sensor at the I band that acts to sense stretch or agonists induced by GPCR (Gq) signaling to restrict or lock the range at which physiological sarcomere length can extend following stretch and/or to scaffold Gq/stress-induced interactions of MAPK components at titin N2B in order to mediate ensuing hypertrophic signaling, which can lead to pathological cardiac hypertrophy. Right: Loss of FHL1 leads to unlocking and/or destabilization of the macromolecular MAPK/FHL1/titin complex in cardiomyocytes, thereby resulting in increased passive elasticity and sarcomere extensibility and/or loss of the ability to scaffold Gq/stress-induced interactions of MAPK at the I band, resulting in reduced hypertrophic signaling and a blunted response to cardiac hypertrophy.